We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
(+19%)
Cap. Flow
+$417M
Cap. Flow
% of AUM
8.07%
Top 10 Holdings %
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$43.8M |
| 2 |
Gilead Sciences
GILD
|
+$40.8M |
| 3 |
GE Aerospace
GE
|
+$37.3M |
| 4 |
Motorola Solutions
MSI
|
+$24.6M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$23.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$53.2M |
| 2 |
Amgen
AMGN
|
+$30.4M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$21.5M |
| 4 |
Canadian National Railway
CNI
|
+$20.9M |
| 5 |
Becton Dickinson
BDX
|
+$18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.05% |
| 2 | Financials | 13.76% |
| 3 | Technology | 12.91% |
| 4 | Communication Services | 9.31% |
| 5 | Industrials | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Texas Instruments
TXN
$255B
| $9.52M | 0.18% |
118,143
-135,242
| -53% | -$10.5M |
|
152
Pampa Energía
PAM
$4.64B
| $9.44M | 0.18% |
174,000
-116,000
| -40% | -$5.35M |
|
153
Church & Dwight Co
CHD
$23.1B
| $9.42M | 0.18% |
188,810
+176,198
| +1,397% | +$8.42M |
|
154
Credicorp
BAP
$30.9B
| $9.29M | 0.18% |
56,900
+26,000
| +84% | +$4.27M |
|
155
Lowe's Companies
LOW
$116B
| $9.16M | 0.18% |
111,399
+32,123
| +41% | +$2.46M |
|
156
Harley-Davidson
HOG
$2.68B
| $8.77M | 0.17% |
144,974
+137,321
| +1,794% | +$8.07M |
|
157
Thermo Fisher Scientific
TMO
$211B
| $8.64M | 0.17% |
56,253
-37,194
| -40% | -$5.68M |
|
158
NVIDIA
NVDA
$5.01T
| $8.6M | 0.17% |
3,157,600
+1,294,200
| +69% | +$3.44M |
|
159
Boston Scientific
BSX
$65.8B
| $8.54M | 0.17% |
343,432
-9,327
| -3% | -$227K |
|
160
Travel + Leisure Co
TNL
$4.54B
| $8.52M | 0.16% |
223,781
+6,038
| +3% | +$222K |
|
|
KITE
161
DELISTED
Kite Pharma, Inc.
KITE
| $8.36M | 0.16% |
106,550
-130,000
| -55% | -$8.04M |
|
162
Tesla
TSLA
$1.24T
| $8.32M | 0.16% |
448,185
+67,950
| +18% | +$1.15M |
|
163
Akamai
AKAM
$16.8B
| $8.29M | 0.16% |
138,768
+58,035
| +72% | +$3.81M |
|
164
Equity Residential
EQR
$25.4B
| $8.06M | 0.16% |
129,586
+51,506
| +66% | +$3.22M |
|
165
Honeywell
HON
$77.1B
| $8.02M | 0.16% |
71,057
+13,961
| +24% | +$1.54M |
|
|
BSMX
166
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $7.9M | 0.15% |
+875,000
| New | +$6.65M |
|
|
AET
167
DELISTED
Aetna Inc
AET
| $7.88M | 0.15% |
61,741
-36,012
| -37% | -$4.52M |
|
168
Deere & Co
DE
$170B
| $7.87M | 0.15% |
72,260
+52,310
| +262% | +$5.67M |
|
169
Aramark
ARMK
$15B
| $7.73M | 0.15% |
290,227
-68,423
| -19% | -$1.74M |
|
170
Fidelity National Information Services
FIS
$21.5B
| $7.7M | 0.15% |
96,686
+12,861
| +15% | +$1.03M |
|
|
HOLX
171
DELISTED
Hologic
HOLX
| $7.7M | 0.15% |
180,865
-29,919
| -14% | -$1.22M |
|
172
Ionis Pharmaceuticals
IONS
$9.35B
| $7.68M | 0.15% |
191,000
+43,000
| +29% | +$1.93M |
|
|
CLVS
173
DELISTED
Clovis Oncology, Inc.
CLVS
| $7.64M | 0.15% |
120,000
-11,000
| -8% | -$669K |
|
174
State Street
STT
$50.9B
| $7.61M | 0.15% |
95,633
-40,052
| -30% | -$3.18M |
|
175
Universal Health Services
UHS
$9.43B
| $7.52M | 0.15% |
60,458
-10,675
| -15% | -$1.26M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q1 2017 Portfolio in Review
As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.
- Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
- Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
- Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
- Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
- Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
- Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
- Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.
Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.